Cargando…

No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years

The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradication of HIV. This reservoir is stable over long periods of time despite antiretroviral therapy. There has been controversy on whether low level viral replication is occurring at sanctuary sites periodic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Hoi Ping, Norton, Nicholas J., Hirst, Jack C, Fun, Axel, Bandara, Mikaila, Wills, Mark R., Lever, Andrew M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805784/
https://www.ncbi.nlm.nih.gov/pubmed/29422601
http://dx.doi.org/10.1038/s41598-018-20682-w
_version_ 1783299026933776384
author Mok, Hoi Ping
Norton, Nicholas J.
Hirst, Jack C
Fun, Axel
Bandara, Mikaila
Wills, Mark R.
Lever, Andrew M. L.
author_facet Mok, Hoi Ping
Norton, Nicholas J.
Hirst, Jack C
Fun, Axel
Bandara, Mikaila
Wills, Mark R.
Lever, Andrew M. L.
author_sort Mok, Hoi Ping
collection PubMed
description The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradication of HIV. This reservoir is stable over long periods of time despite antiretroviral therapy. There has been controversy on whether low level viral replication is occurring at sanctuary sites periodically reseeding infected cells into the latent reservoir to account its durability. To study viral evolution in a physiologically relevant population of latent viruses, we repeatedly performed virus outgrowth assays on a stably treated HIV positive patient over two years and sequenced the reactivated latent viruses. We sought evidence of increasing sequence pairwise distances with time as evidence of ongoing viral replication. 64 reactivatable latent viral sequences were obtained over 103 weeks. We did not observe an increase in genetic distance of the sequences with the time elapsed between sampling. No evolution could be discerned in these reactivatable latent viruses. Thus, in this patient, the contribution of low-level replication to the maintenance of the latent reservoir detectable in the blood compartment is limited.
format Online
Article
Text
id pubmed-5805784
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58057842018-02-16 No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years Mok, Hoi Ping Norton, Nicholas J. Hirst, Jack C Fun, Axel Bandara, Mikaila Wills, Mark R. Lever, Andrew M. L. Sci Rep Article The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradication of HIV. This reservoir is stable over long periods of time despite antiretroviral therapy. There has been controversy on whether low level viral replication is occurring at sanctuary sites periodically reseeding infected cells into the latent reservoir to account its durability. To study viral evolution in a physiologically relevant population of latent viruses, we repeatedly performed virus outgrowth assays on a stably treated HIV positive patient over two years and sequenced the reactivated latent viruses. We sought evidence of increasing sequence pairwise distances with time as evidence of ongoing viral replication. 64 reactivatable latent viral sequences were obtained over 103 weeks. We did not observe an increase in genetic distance of the sequences with the time elapsed between sampling. No evolution could be discerned in these reactivatable latent viruses. Thus, in this patient, the contribution of low-level replication to the maintenance of the latent reservoir detectable in the blood compartment is limited. Nature Publishing Group UK 2018-02-08 /pmc/articles/PMC5805784/ /pubmed/29422601 http://dx.doi.org/10.1038/s41598-018-20682-w Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Mok, Hoi Ping
Norton, Nicholas J.
Hirst, Jack C
Fun, Axel
Bandara, Mikaila
Wills, Mark R.
Lever, Andrew M. L.
No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title_full No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title_fullStr No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title_full_unstemmed No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title_short No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years
title_sort no evidence of ongoing evolution in replication competent latent hiv-1 in a patient followed up for two years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805784/
https://www.ncbi.nlm.nih.gov/pubmed/29422601
http://dx.doi.org/10.1038/s41598-018-20682-w
work_keys_str_mv AT mokhoiping noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT nortonnicholasj noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT hirstjackc noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT funaxel noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT bandaramikaila noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT willsmarkr noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears
AT leverandrewml noevidenceofongoingevolutioninreplicationcompetentlatenthiv1inapatientfollowedupfortwoyears